Liver Metastatic Colorectal Tumor Cells Change Their Phenotype During Consecutive Passages on Chick Embryo Chorioallantoic Membrane: Lessons from the Lab to the Clinic

Background/Aim: Colon cancer liver metastases with desmoplastic growth pattern (dGP) have a highly heterogeneous therapy response. The aim of the study was to evaluate the dGP liver metastasis molecular profile from a chemo-naive patient by mimicking metastatic process on an experimental chick embryo chorioallantoic membrane (CAM) model. Materials and Methods: Three successive CAM passages of dGP human colorectal liver metastases were immunophenotyped for keratin (K) 8, and 20, CLIC1, VEGF, EGFR, CD34, podoplanin, Ki67, E-cadherin and vimentin. Results: Metastatic cells gradually lost K20 while K8, E-cadherin and vimentin heterogeneously increased during passages. VEGF, CLIC 1, EGFR expression increased in metastatic cells especially at the tumor graft periphery. Scattered proliferating and non-proliferating podoplanin-positive tumor cells, lymphatic and blood vessels were heterogeneously detected in tumor xenografts depending on passage stage. Conclusion: By mimicking repetitive metastatic processes we proved that metastatic cells change their phenotype. This may explain why not all metastases have a similar response to therapy.

[1]  H. Alexandrino,et al.  Prognostic Factors After Hepatectomy for Gastric Adenocarcinoma Liver Metastases: Desmoplastic Growth Pattern as the Key to Improved Overall Survival , 2020, Cancer management and research.

[2]  M. Ronot,et al.  Colorectal liver metastases: radiopathological correlation , 2020, Insights into Imaging.

[3]  Elsa N Garza-Treviño,et al.  Colorectal Cancer Stem Cells in the Progression to Liver Metastasis , 2020, Frontiers in Oncology.

[4]  T. Gruenberger,et al.  Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases , 2020, British Journal of Cancer.

[5]  Luqing Zhao,et al.  Diagnostic performance of magnetic resonance imaging for colorectal liver metastasis: A systematic review and meta-analysis , 2020, Scientific Reports.

[6]  H. Ueno,et al.  Morphological consistency of desmoplastic reactions between the primary colorectal cancer lesion and associated metastatic lesions , 2020, Virchows Archiv.

[7]  M. Mazzanti,et al.  Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity , 2019, Front. Oncol..

[8]  Luc Y Dirix,et al.  Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases , 2019, Angiogenesis.

[9]  G. Lopez,et al.  Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma , 2018, International journal of molecular sciences.

[10]  P. van Dam,et al.  Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy. , 2018, Seminars in cancer biology.

[11]  V. Servois,et al.  Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases , 2018, The journal of pathology. Clinical research.

[12]  M. Raica,et al.  The Mesenchymal-Epithelial and Epithelial-Mesenchymal Cellular Plasticity of Liver Metastases with Digestive Origin. , 2018, Anticancer research.

[13]  H. Alexandrino,et al.  Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - Pushing growth as an independent risk factor for decreased survival. , 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[14]  R. Pathak,et al.  The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research. , 2018, American journal of cancer research.

[15]  Yves Sucaet,et al.  International consensus guidelines for scoring the histopathological growth patterns of liver metastasis , 2017, British Journal of Cancer.

[16]  B. Barrera-mera,et al.  Hepatic Metastasis from Colorectal Cancer , 2017, Euroasian journal of hepato-gastroenterology.

[17]  William H. Bisson,et al.  Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions , 2017, Cellular and molecular gastroenterology and hepatology.

[18]  O. Crețu,et al.  The tyrosine kinase inhibitors effects on metastatic tumor graft in the chick chorioallantoic membrane assay. , 2017, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[19]  M. Tez,et al.  Role of surgery in colorectal cancer liver metastases. , 2014, World journal of gastroenterology.

[20]  R. Parks,et al.  Perioperative FOLFOX 4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer ( EORTC 40983 ) : long-term results of a randomised , controlled , phase 3 trial , 2013 .

[21]  N. Marceau,et al.  Keratins modulate hepatic cell adhesion, size and G1/S transition. , 2007, Experimental cell research.

[22]  E. van Marck,et al.  Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia , 2004, British Journal of Cancer.